Therapy Development
Characterization and Potential Mitigation of Corneal Effects in Nonclinical Toxicology Studies in Animals Administered Depatuxizumab Mafodotin
Journal of Ocular Pharmacology and Therapeutics. 2022 Sep 1;38(7):471-80
Ocular distribution and efficacy after suprachoroidal injection of AU-011 for treatment of ocular melanoma
Investigative Ophthalmology & Visual Science, 61(7), pp.3615-3615
Ocular Safety of AAV2. 7m8-ChrimsonR-tdTomato (GS030-DP) following intravitreous injection and exposure to 595 nm LED light in blind rd1 mice
Investigative Ophthalmology & Visual Science, 59(9), pp.5658-5658
Preliminary tolerability of iPSC-Derived RPE on PLGA scaffold implantation in RNU Nude Rats
American Society of Gene & Cell Therapy Annual Meeting. Mol Ther; 25(5S1)
Cone-specific promoters for gene therapy of achromatopsia and other retinal diseases
Human gene therapy, 27(1), pp.72-82
AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases
Investigative Ophthalmology & Visual Science, 53(4), pp.2170-2180
Safety And Tolerability Of Retinostat®, A Lentiviral-vector Based Gene Therapy Product For The Treatment Of Wet Age-related Macular Degeneration, In Rabbits And Monkeys
Investigative Ophthalmology & Visual Science, 52(14), pp.488-488
INO-8875, an adenosine A1 agonist, lowers intraocular pressure through the conventional outflow pathway
Investigative Ophthalmology & Visual Science, 51(13), pp.3238-3238